Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bijoy Chandapillai Karikkineth"'
Autor:
Ahmad-Fawad Jebran, Malte Tiburcy, Daniel Biermann, Paul Balfanz, Michael Didié, Bijoy Chandapillai Karikkineth, Friedrich Schöndube, Ingo Kutschka, Wolfram-Hubertus Zimmermann
Publikováno v:
Journal of molecular and cellular cardiology 168, 3-12 (2022). doi:10.1016/j.yjmcc.2022.03.013
Engineered heart muscle (EHM) can be implanted epicardially to remuscularize the failing heart. In case of a severely scarred ventricle, excision of scar followed by transmural heart wall replacement may be a more desirable application. Accordingly,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8450b6a12121864a20bb8c61a6a99b3c
https://publica.fraunhofer.de/handle/publica/437270
https://publica.fraunhofer.de/handle/publica/437270
Autor:
Masato Sasaki, Keiichi Torimitsu, Matsuhiko Nishizawa, Kuniaki Nagamine, Hirokazu Kaji, Bijoy Chandapillai Karikkineth
Publikováno v:
Advanced healthcare materials. 3(11)
Hydrogel-based, molecular permeable electronic devices are considered to be promising for electrical stimulation and recording of living tissues, either in vivo or in vitro. This study reports the fabrication of the first hydrogel-based devices that
Autor:
Michael Grimm, Doerthe M Katschinksi, Hiroshi Naito, Peter Christalla, Ali El-Armouche, Monika Nose, Michael Didié, Stephan Döker, Thomas Eschenhagen, Oliver Boy, Nazha Hamdani, Wolfram-Hubertus Zimmermann, Bijoy Chandapillai Karikkineth, Anke Zieseniss, Manuel Mayr, Xiaoke Yin, Malte Tiburcy, Wolfgang A. Linke
Publikováno v:
Tiburcy, M, Didie, M, Boy, O, Christalla, P, Doker, S, Naito, H, Karikkineth, B C, El-Armouche, A, Grimm, M, Nose, M, Eschenhagen, T, Zieseniss, A, Katschinksi, D M, Hamdani, N, Linke, W A, Yin, X K, Mayr, M & Zimmermann, W H 2011, ' Terminal Differentiation, Advanced Organotypic Maturation, and Modeling of Hypertrophic Growth in Engineered Heart Tissue ', Circulation Research, vol. 109, no. 10, pp. 1105-1114 . https://doi.org/10.1161/CIRCRESAHA.111.251843
Circulation Research, 109(10), 1105-1114. Lippincott Williams and Wilkins
Circulation Research, 109(10), 1105-1114. Lippincott Williams and Wilkins
Rationale: Cardiac tissue engineering should provide “realistic” in vitro heart muscle models and surrogate tissue for myocardial repair. For either application, engineered myocardium should display features of native myocardium, including termin
Publikováno v:
Current pharmaceutical biotechnology. 14(1)
Cardiovascular diseases, including myocardial infarction and heart failure, are the main causes of death worldwide. Classical pharmacological treatment may halt, but cannot reverse the underlying disease process. Cellular cardiomyoplasty has the pote
Autor:
Bijoy Chandapillai Karikkineth, WH Zimmermann, Malte Tiburcy, Stephan Rosenkranz, Marius Vantler, Michael Didié, Hiroshi Naito, Monika Nose
Publikováno v:
Journal of molecular and cellular cardiology. 48(6)
Platelet-derived-growth-factor-BB (PDGF-BB) can protect various cell types from apoptotic cell death, and induce hypertrophic growth and proliferation, but little is known about its direct or indirect effects on cardiomyocytes. Cardiac muscle enginee
Autor:
Daniel Biermann, Michael Didié, Bijoy Chandapillai Karikkineth, Claudia Lange, Thomas Eschenhagen, Wolfram H Zimmermann
Publikováno v:
Circulation. 116
Engineered Heart Tissue (EHT) can be utilized to partially repair infarcted myocardium in rats. Here, we investigated the feasibility of EHT-grafts as transmural wall replacement in a heterotopic transplantation model. Methods: EHTs (diameter: 15 mm,
Autor:
Yalin Yildirim, Michael Didié, D. Biermann, Wolfram-Hubertus Zimmermann, Hiroshi Naito, Thomas Eschenhagen, Bijoy Chandapillai Karikkineth
Publikováno v:
Circulation. 116
Background— Engineered heart tissue (EHT) can be generated from cardiomyocytes and extracellular matrix proteins and used to repair local heart muscle defects in vivo. Here, we hypothesized that pouch-like heart muscle constructs can be generated b